DARPP-32 and NCS-1 expression is not altered in brains of rats treated with typical or atypical antipsychotics

Neurochemical Research

Volumn 33, Issue 3, 2008, Pages 533-538

  Souza, Bruno R ^a   Motta, Bernardo S ^a   Rosa, Daniela V F ^a   Torres, Karen C L ^a   Castro, Adalberto A ^b   Comim, Clarissa M ^b   Sampaio, André M ^a   Lima, Fabrício F ^a   Jeromin, Andreas ^c   Quevedo, João ^b   Romano Silva, Marco A ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Antipsychotic; DARPP 32; NCS 1; Schizophrenia

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; HALOPERIDOL; NCS 1 PROTEIN; NEUROLEPTIC AGENT; NEURONAL CALCIUM SENSOR; OLANZAPINE; PHOSPHOPROTEIN DARPP 32; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; HIPPOCAMPUS; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTIPSYCHOTIC AGENTS; BLOTTING, WESTERN; BRAIN CHEMISTRY; DENSITOMETRY; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; MALE; NEURONAL CALCIUM-SENSOR PROTEINS; NEUROPEPTIDES; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; UP-REGULATION;

RATTUS;

EID: 38949103324     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9470-2     Document Type: Article

References (38)

1. Giros B, Jaber M, Jones SR et al (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-612
2. Packard MG, Knowlton BJ (2002) Learning and memory functions of the Basal Ganglia. Annu Rev Neurosci 25:563-593
3. Lourenco GA, Dorce VA, Palermo-Neto J (2005) Haloperidol treatments increased macrophage activity in male and female rats: influence of corticosterone and prolactin serum levels. Eur Neuropsychopharmacol 15:271-277
4. Kavelaars A, Cobelens PM, Teunis MA et al (2005) Changes in innate and acquired immune responses in mice with targeted deletion of the dopamine transporter gene. J Neuroimmunol 161:162-168
5. Seeman P (1992) Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacology 7:261-284
6. Bergson C, Levenson R, Goldman-Rakic PS et al (2003) Dopamine receptor-interacting proteins: the Ca(2+) connection in dopamine signaling. Trends Pharmacol Sci 24:486-492
7. Foubister V (2002) Do all paths lead to DARPP-32? Drug Discov Today 7:1068-1070
8. Mueser KT, McGurk SR (2004) Schizophrenia. Lancet 363:2063-2072
9. Souza BR, Souza RP, Rosa DV et al (2006) Dopaminergic intracellular signal integrating proteins: relevance to schizophrenia. Dialogues Clin Neurosci 8:95-100
10. Albert KA, Hemmings HC Jr, Adamo AI et al (2002) Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia. Arch Gen Psychiatry 59:705-712
11. Ishikawa M, Mizukami K, Iwakiri M, Asada T (2007) Immunohistochemical and immunoblot analysis of Dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry [Epub ahead of print]
12. Stoof JC, Kebabian JW (1981) Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294:366-368
13. Nishi A, Snyder GL, Greengard P (1997) Bidirectional regulation of DARPP-32 phosphorylation by dopamine. J Neurosci 17:8147-8155
14. Svenningsson P, Lindskog M, Ledent C et al (2000) Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proc Natl Acad Sci USA 97:1856-1860
15. Lindskog M, Svenningsson P, Fredholm BB et al (1999) Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms. Neuroscience 88:1005-1008
16. Svenningsson P, Nishi A, Fisone G et al (2004) DARPP-32: an integrator of neurotransmission. Annu Rev Pharmacol Toxicol 44:269-296
17. Koh PO, Undie AS, Kabbani N et al (2003) Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients. Proc Natl Acad Sci USA 100:313-317
18. Bai J, He F, Novikova SI et al (2004) Abnormalities in the dopamine system in schizophrenia may lie in altered levels of dopamine receptor-interacting proteins. Biol Psychiatry 56:427-440
19. Nakayama S, Moncrief ND, Kretsinger RH (1992) Evolution of EF-hand calcium-modulated proteins. II. Domains of several subfamilies have diverse evolutionary histories. J Mol Evol 34:416-448
20. Nef S, Fiumelli H, de Castro E et al (1995) Identification of neuronal calcium sensor (NCS-1) possibly involved in the regulation of receptor phosphorylation. J Recept Signal Transduct Res 15:365-378
21. Ames JB, Ishima R, Tanaka T et al (1997) Molecular mechanics of calcium-myristoyl switches. Nature 389:198-202
22. 2+ signal transduction. J Biol Chem 277:14227-14237
23. O'Callaghan DW, Burgoyne RD (2003) Role of myristoylation in the intracellular targeting of neuronal calcium sensor (NCS) proteins. Biochem Soc Trans 31:963-965
24. Martone ME, Edelmann VM, Ellisman MH et al (1999) Cellular and subcellular distribution of the calcium-binding protein NCS-1 in the central nervous system of the rat. Cell Tissue Res 295:395-407
25. Kabbani N, Negyessy L, Lin R et al (2002) Interaction with neuronal calcium sensor NCS-1 mediates desensitization of the D2 dopamine receptor. J Neurosci 22:8476-8486
26. Callier S, Snapyan M, Le Crom S et al (2003) Evolution and cell biology of dopamine receptors in vertebrates. Biol Cell 95:489-502
27. Iwata K, Ito K, Fukuzaki A et al (1999) Dynamin and rab5 regulate GRK2-dependent internalization of dopamine D2 receptors. Eur J Biochem 263:596-602
28. Negyessy L, Goldman-Rakic PS (2005) Subcellular localization of the dopamine D2 receptor and coexistence with the calcium-binding protein neuronal calcium sensor-1 in the primate prefrontal cortex. J Comp Neurol 488:464-475
29. Seeman P (2006) Targeting the dopamine D2 receptor in schizophrenia. Expert Opin Ther Targets 10:515-531
30. Reinke A, Martins MR, Lima MS et al (2004) Haloperidol and clozapine, but not olanzapine, induces oxidative stress in rat brain. Neurosci Lett 372:157-160
31. Polydoro M, Schröder N, Lima MNM et al (2004) Haloperidol- and clozapine-induced oxidative stress in the rat brain. Pharmacol Biochem Behav 78:751-756
32. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
33. Bonci A, Hopf FW (2005) The dopamine D2 receptor: new surprises from an old friend. Neuron 47:335-338
34. Meyer-Lindenberg A, Straub RE, Lipska BK et al (2007) Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition. J Clin Invest 117:672-682
35. Grebb JA, Girault JA, Ehrlich M et al (1990) Chronic treatment of rats with SCH-23390 or raclopride does not affect the concentrations of DARPP-32 or its mRNA in dopamine-innervated brain regions. J Neurochem 55:204-207
36. Guitart X, Nestler EJ (1992) Chronic administration of lithium or other antidepressants increases levels of DARPP-32 in rat frontal cortex. J Neurochem 59:1164-1167
37. Krupnick JG, Benovic JL (1998) The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol 38:289-319
38. Kim KM, Valenzano KJ, Robinson SR et al (2001) Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and beta-arrestins. J Biol Chem 276:37409-37414